Results 81 to 90 of about 548 (135)
Some of the next articles are maybe not open access.
Atherosclerosis in primary antiphospholipid syndrome
Expert Review of Clinical Immunology, 2006Antiphospholipid syndrome (APS) is the most common cause of acquired thrombophilia, but experimental and clinical evidence accumulated over the years suggest that the clinical manifestations of APS go beyond those of a simple hypercoagulable state.
Paul R J, Ames +6 more
openaire +2 more sources
Chorea in primary antiphospholipid syndrome
Clinical Neurology and Neurosurgery, 1996A 12-year-old girl with chorea, thrombocytopenia and false positive VDRL had negative serological tests for SLE, but high titre of antiocardiolipine antibodies. Primary antiphospholipid antibody syndrome is rarely complicated by chorea, but should be taken into consideration in patients who do not fulfill the diagnostic criteria for SLE.
C. Masala +3 more
openaire +3 more sources
Belimumab in primary antiphospholipid syndrome
Lupus, 2016[No abstract available]
Yazici, A., Yazirli, B., Erkan, D.
openaire +3 more sources
Primary antiphospholipid syndrome with and without Sneddon’s syndrome
Rheumatology International, 2009The main objective of this study was to compare clinical and laboratory data obtained from patients with primary antiphospholipid syndrome (PAPS) with and without Sneddon's syndrome (SS). A transverse study with 54 (85.2% female) PAPS patients (Sapporo criteria) was performed.
Cezar Augusto Muniz, Caldas +1 more
openaire +2 more sources
Primary Antiphospholipid Syndrome
2006PAPS has emerged as an important disease entity. Depending on the organ systems involved, it can produce a highly variable clinical picture, with severity ranging from mild asymptomatic disease (often undiagnosed) to major life-threatening events. It may be regarded as the pure form of a condition which is also frequently seen in the context of other ...
Tonia L. Vincent +1 more
openaire +1 more source
Primary Antiphospholipid Syndrome and Pulmonary Hypertension
Current Pharmaceutical Design, 2014Primary antiphospholipid syndrome (APS) is a disease characterized by the presence of autoantibodies reacting with proteins bound to phospholipids, leading to thrombosis and gestation abnormalities. Prothrombotic states and impaired clot dissolution are believed to contribute to the occurrence of chronic thromboembolic pulmonary hypertension (CTEPH) in
Aibek E, Mirrakhimov, Nicholas S, Hill
openaire +2 more sources
The Primary Antiphospholipid Syndrome
2000The emergence of the antiphospholipid syndrome (APS) over the last thirty-odd years has been one of the most striking developments in clinical autoimmunity. The identification of a pure or “primary” variant of the syndrome has been central to this story, not least in enabling us to establish the place of this remarkable condition in the wide spectrum ...
T. Vincent, C. Mackworth-Young
openaire +1 more source
Familial Occurrence of Primary Antiphospholipid Syndrome
Thrombosis Research, 1999venom (dRVV) were prolonged. LA was found positive according to the criteria of the scientific subcommittee for LA [11]. ACAs were also positive (Table 1).
A, Cantalapiedra +3 more
openaire +2 more sources
Subclinical Atherosclerosis in Primary Antiphospholipid Syndrome
Annals of the New York Academy of Sciences, 2007Abstract: To test the atherosclerosis hypothesis in primary antiphospholipid syndrome (PAPS) we measured intima media thickness (IMT) of carotid arteries and other cardiovascular risk factors in 44 patients with PAPS (mean age 35 ± 12 years), in 25 patients with inherited thrombophilia (mean age 40 ± 10 years), and in 34 normal controls (mean age 38 ±
Annamaria, Margarita +7 more
openaire +2 more sources
IgA deficiency in primary antiphospholipid syndrome
Joint Bone Spine, 2014Joint Bone Spine - In Press.Proof corrected by the author Available online since mercredi 26 juin ...
Camila Cristina, Bonin +2 more
openaire +2 more sources